Article (Scientific journals)
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer
Mattson, Karin; Vansteenkiste, Johan; Stupp, Roger et al.
2000In Anti-Cancer Drugs, 11, p. 7-13
Peer Reviewed verified by ORBi
 

Files


Full Text
150.pdf
Publisher postprint (580.18 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
alternating schedule; cisplatin; docetaxel; firstline chemotherapy; non-small lung cancer
Disciplines :
Hematology
Author, co-author :
Mattson, Karin
Vansteenkiste, Johan
Stupp, Roger
Bargetzi, Mario
Saarinen, Antti
Jekunen, Antti
Fillet, Georges ;  Université de Liège - ULiège > Département des sciences cliniques > Hématologie - Oncologie médicale
Teixeira, Maria
Gatzemeier, Ulrich
Olivares, Robert
Soussan-Lazard, Karen
Berille, Jocelyne
Language :
English
Title :
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancer
Publication date :
2000
Journal title :
Anti-Cancer Drugs
ISSN :
0959-4973
eISSN :
1473-5741
Publisher :
Lippincott Williams & Wilkins, London, United Kingdom
Volume :
11
Pages :
7-13
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 20 May 2009

Statistics


Number of views
42 (5 by ULiège)
Number of downloads
400 (1 by ULiège)

Scopus citations®
 
8
Scopus citations®
without self-citations
7
OpenCitations
 
5

Bibliography


Similar publications



Contact ORBi